235 related articles for article (PubMed ID: 22896930)
21. Prediction of lateral lymph node metastases in medullary thyroid cancer.
Machens A; Hauptmann S; Dralle H
Br J Surg; 2008 May; 95(5):586-91. PubMed ID: 18300267
[TBL] [Abstract][Full Text] [Related]
22. Cytologic diagnosis of recurrent medullary thyroid carcinoma with oncocytic change twenty-one years post-thyroidectomy: case report and review of the literature.
Tranchida P; Estigarribia J; Sethi S; Giorgadze T
Diagn Cytopathol; 2011 Sep; 39(9):641-6. PubMed ID: 20949456
[TBL] [Abstract][Full Text] [Related]
23. Medullary thyroid carcinoma: a 20-year experience from a centre in South India.
Finny P; Jacob JJ; Thomas N; Philip J; Rajarathnam S; Oommen R; Nair A; Seshadri MS
ANZ J Surg; 2007 Mar; 77(3):130-4. PubMed ID: 17305985
[TBL] [Abstract][Full Text] [Related]
24. Locoregional control in patients with palpable medullary thyroid cancer: results of standardized compartment-oriented surgery.
de Groot JW; Links TP; Sluiter WJ; Wolffenbuttel BH; Wiggers T; Plukker JT
Head Neck; 2007 Sep; 29(9):857-63. PubMed ID: 17427969
[TBL] [Abstract][Full Text] [Related]
25. Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer.
Greenblatt DY; Elson D; Mack E; Chen H
Asian J Surg; 2007 Apr; 30(2):108-12. PubMed ID: 17475579
[TBL] [Abstract][Full Text] [Related]
26. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of the lateral neck compartment for metastatic thyroid cancer.
Dralle H; Machens A
Curr Opin Oncol; 2013 Jan; 25(1):20-6. PubMed ID: 23079930
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
29. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
30. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
[TBL] [Abstract][Full Text] [Related]
31. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
[TBL] [Abstract][Full Text] [Related]
32. The value of intraoperative pentagastrin testing in medullary thyroid cancer.
Scheuba C; Bieglmayer C; Asari R; Kaczirek K; Izay B; Kaserer K; Niederle B
Surgery; 2007 Feb; 141(2):166-71; discussion 171-2. PubMed ID: 17263971
[TBL] [Abstract][Full Text] [Related]
33. [Indication and extent of cervical lymph node dissection in differentiated thyroid carcinoma].
Kayser C; Tittelbach-Helmrich D; Meyer S; Thomusch O
Zentralbl Chir; 2011 Aug; 136(4):364-73. PubMed ID: 20711956
[TBL] [Abstract][Full Text] [Related]
34. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
35. Importance of lymph node metastases in follicular thyroid cancer.
Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
[TBL] [Abstract][Full Text] [Related]
36. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
37. Neck management in medullary thyroid carcinoma.
Oskam IM; Hoebers F; Balm AJ; van Coevorden F; Bais EM; Hart AM; van den Brekel MW
Eur J Surg Oncol; 2008 Jan; 34(1):71-6. PubMed ID: 17555910
[TBL] [Abstract][Full Text] [Related]
38. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
39. [Medullary carcinoma of the thyroid: a clinical contribution].
Angeli G; Brazzarola P; Bottura D; Bonomo S; Castellini C; Moser A; Vicenzi L; Mazzola F; Rizzo S; Betresini B; Ballarin A; Rosa G
Chir Ital; 2002; 54(1):25-9. PubMed ID: 11942005
[TBL] [Abstract][Full Text] [Related]
40. Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.
Raval MV; Sturgeon C; Bentrem DJ; Elaraj DM; Stewart AK; Winchester DJ; Ko CY; Reynolds M
J Pediatr Surg; 2010 Oct; 45(10):1947-54. PubMed ID: 20920711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
